Natasha Mirella Ramirez, FNP-BC, MSN, RN

Natasha Ramirez practices at Kaiser Permanente South Bay Medical Center in Harbor City, California, part of Kaiser Permanente.

Natasha Ramirez's NPI, 1013553064, was assigned on November 25, 2019. Natasha Ramirez holds California license 95013325.

Natasha Ramirez's primary practice is Kaiser Permanente South Bay Medical Center, at 25825 South Vermont Avenue, Harbor City, CA 90710 in Los Angeles County. The practice phone is (310) 325-5111.

Natasha Ramirez's primary practice is Kaiser Permanente South Bay Medical Center in Harbor City, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Natasha Ramirez to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Natasha Ramirez practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Natasha Ramirez's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Natasha Ramirez is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, arthritis, asthma, bladder disease, broken or dislocated ankle/ or foot, chronic obstructive pulmonary disease (COPD) and conjunctivitis among the conditions Natasha Ramirez treats.

CMS data shows 224 Medicare services from Natasha Ramirez across 4 procedure codes in 2024, for 195 Medicare patients. Medicare paid $9,096 for them. Every service was in an office.

CMS counts 195 Medicare patients who saw Natasha Ramirez in 2024. The largest group is 65 to 74, with 85 patients. 74% of them have high blood pressure, and 65% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Natasha Ramirez's median patient age at 40, with 78% women.

In 2024, Natasha Ramirez wrote 801 Medicare Part D claims for 470 patients. 91% of them were for generic drugs. CMS names the drug for 547 of them, across 22 drugs with 11 or more claims each, at $6,527 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Natasha Ramirez for performance year 2024, reported as part of a group. Natasha Ramirez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.